I'm sorry, I'm unable to listen myself (too ill). I'll try to listen back to the recording later, when I can pause often etc. I'll let you know if I find any written summaries posted in any of the Swedish groups.Interested in some kind of summary of Zaher's talk, if it's possible, given that he's now employed by an arthritis organisation. I'm wondering if he indicates that they will be pursuing research into specifically ME.
Awesome, thanks.@Andy he just presented an overview of the centers and other research efforts in the US, as well as outlining all the information gaps in ME research (news flash: it’s all gaps, zero knowledge).
Other than that he is very optimistic for the field of ME/CFS - “more ladders than chutes”
Yes, the recording will be on YouTube later.Argh! I was going to watch Nahle but have just realised that the UK is an hour behind and I've missed him.
Will this be on YouTube later?
They are going to be repeated the next day (October 18th), on 14:10 and 16:00 respectively. Looking forward to this!
I am too slow for this - just posted on the thread on the Stanford symposium.
In case anyone was/ is watching the contribution on the Rituximab trials, I copy my question over here:
I know from people with RA and MS treated with Rituximab that they get high dose cortisone and antihistamines immediately prior to the Rituximab infusion to reduce the risk of severe side effects. Does anybody know whether the participants of the Norwegian trials also got cortisone? And if they got, could this have any relevance, e.g. that some of the "responders" of the first trial phases benefited rather from the high dose cortisone than from Rituximab?
Thank you @andypants.They were all given cortisone. Unlikely that it affected outcomes as it’s out of the body quickly.
Livestreams have now been scheduled on YouTube:
ME/CFS-dagarna 2018 - Stockholm
ME/CFS-dagarna 2018 - Göteborg